TrialPhytotherapy research : PTR2015
Tolerance of Phellodendron amurense bark extract (Nexrutine®) in patients with human prostate cancer.
Gregory P Swanson et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
12 papers cite it
this papercites it